- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
According to our latest study, the global Neurological Biomarkers market size was valued at USD 7137.8 million in 2022 and is forecast to a readjusted size of USD 15280 million by 2029 with a CAGR of 11.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
This report is a detailed and comprehensive analysis for global Neurological Biomarkers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurological Biomarkers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurological Biomarkers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurological Biomarkers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurological Biomarkers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Biomarkers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Biomarkers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott and Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neurological Biomarkers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
Major players covered
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Biomarkers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Biomarkers, with price, sales, revenue and global market share of Neurological Biomarkers from 2018 to 2023.
Chapter 3, the Neurological Biomarkers competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Biomarkers breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurological Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Biomarkers.
Chapter 14 and 15, to describe Neurological Biomarkers sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neurological Biomarkers Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Proteomics
1.3.3 Genomics
1.3.4 Imaging
1.3.5 Bioinformatics
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Neurological Biomarkers Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostics
1.4.3 Drug Discovery
1.4.4 Personalized Medicine
1.4.5 Others
1.5 Global Neurological Biomarkers Market Size & Forecast
1.5.1 Global Neurological Biomarkers Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neurological Biomarkers Sales Quantity (2018-2029)
1.5.3 Global Neurological Biomarkers Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Neurological Biomarkers Product and Services
2.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Neurological Biomarkers Product and Services
2.2.4 Merck Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Neurological Biomarkers Product and Services
2.3.4 Quest Diagnostics Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Quest Diagnostics Recent Developments/Updates
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Neurological Biomarkers Product and Services
2.4.4 Abbott Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Abbott Recent Developments/Updates
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Neurological Biomarkers Product and Services
2.5.4 Roche Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Roche Recent Developments/Updates
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina Neurological Biomarkers Product and Services
2.6.4 Illumina Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Illumina Recent Developments/Updates
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Neurological Biomarkers Product and Services
2.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Rad Laboratories Recent Developments/Updates
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Neurological Biomarkers Product and Services
2.8.4 QIAGEN Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 QIAGEN Recent Developments/Updates
2.9 Myriad RBM
2.9.1 Myriad RBM Details
2.9.2 Myriad RBM Major Business
2.9.3 Myriad RBM Neurological Biomarkers Product and Services
2.9.4 Myriad RBM Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Myriad RBM Recent Developments/Updates
2.10 Cisbio Bioassays
2.10.1 Cisbio Bioassays Details
2.10.2 Cisbio Bioassays Major Business
2.10.3 Cisbio Bioassays Neurological Biomarkers Product and Services
2.10.4 Cisbio Bioassays Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cisbio Bioassays Recent Developments/Updates
2.11 Athena Diagnostics
2.11.1 Athena Diagnostics Details
2.11.2 Athena Diagnostics Major Business
2.11.3 Athena Diagnostics Neurological Biomarkers Product and Services
2.11.4 Athena Diagnostics Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Athena Diagnostics Recent Developments/Updates
2.12 BGI
2.12.1 BGI Details
2.12.2 BGI Major Business
2.12.3 BGI Neurological Biomarkers Product and Services
2.12.4 BGI Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BGI Recent Developments/Updates
2.13 Wuxi APP
2.13.1 Wuxi APP Details
2.13.2 Wuxi APP Major Business
2.13.3 Wuxi APP Neurological Biomarkers Product and Services
2.13.4 Wuxi APP Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Wuxi APP Recent Developments/Updates
2.14 Aepodia
2.14.1 Aepodia Details
2.14.2 Aepodia Major Business
2.14.3 Aepodia Neurological Biomarkers Product and Services
2.14.4 Aepodia Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Aepodia Recent Developments/Updates
2.15 Proteome Sciences
2.15.1 Proteome Sciences Details
2.15.2 Proteome Sciences Major Business
2.15.3 Proteome Sciences Neurological Biomarkers Product and Services
2.15.4 Proteome Sciences Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Proteome Sciences Recent Developments/Updates
2.16 Genewiz
2.16.1 Genewiz Details
2.16.2 Genewiz Major Business
2.16.3 Genewiz Neurological Biomarkers Product and Services
2.16.4 Genewiz Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Genewiz Recent Developments/Updates
3 Competitive Environment: Neurological Biomarkers by Manufacturer
3.1 Global Neurological Biomarkers Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neurological Biomarkers Revenue by Manufacturer (2018-2023)
3.3 Global Neurological Biomarkers Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neurological Biomarkers by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neurological Biomarkers Manufacturer Market Share in 2022
3.4.2 Top 6 Neurological Biomarkers Manufacturer Market Share in 2022
3.5 Neurological Biomarkers Market: Overall Company Footprint Analysis
3.5.1 Neurological Biomarkers Market: Region Footprint
3.5.2 Neurological Biomarkers Market: Company Product Type Footprint
3.5.3 Neurological Biomarkers Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neurological Biomarkers Market Size by Region
4.1.1 Global Neurological Biomarkers Sales Quantity by Region (2018-2029)
4.1.2 Global Neurological Biomarkers Consumption Value by Region (2018-2029)
4.1.3 Global Neurological Biomarkers Average Price by Region (2018-2029)
4.2 North America Neurological Biomarkers Consumption Value (2018-2029)
4.3 Europe Neurological Biomarkers Consumption Value (2018-2029)
4.4 Asia-Pacific Neurological Biomarkers Consumption Value (2018-2029)
4.5 South America Neurological Biomarkers Consumption Value (2018-2029)
4.6 Middle East and Africa Neurological Biomarkers Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Neurological Biomarkers Sales Quantity by Type (2018-2029)
5.2 Global Neurological Biomarkers Consumption Value by Type (2018-2029)
5.3 Global Neurological Biomarkers Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Neurological Biomarkers Sales Quantity by Application (2018-2029)
6.2 Global Neurological Biomarkers Consumption Value by Application (2018-2029)
6.3 Global Neurological Biomarkers Average Price by Application (2018-2029)
7 North America
7.1 North America Neurological Biomarkers Sales Quantity by Type (2018-2029)
7.2 North America Neurological Biomarkers Sales Quantity by Application (2018-2029)
7.3 North America Neurological Biomarkers Market Size by Country
7.3.1 North America Neurological Biomarkers Sales Quantity by Country (2018-2029)
7.3.2 North America Neurological Biomarkers Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Neurological Biomarkers Sales Quantity by Type (2018-2029)
8.2 Europe Neurological Biomarkers Sales Quantity by Application (2018-2029)
8.3 Europe Neurological Biomarkers Market Size by Country
8.3.1 Europe Neurological Biomarkers Sales Quantity by Country (2018-2029)
8.3.2 Europe Neurological Biomarkers Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Neurological Biomarkers Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neurological Biomarkers Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neurological Biomarkers Market Size by Region
9.3.1 Asia-Pacific Neurological Biomarkers Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neurological Biomarkers Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Neurological Biomarkers Sales Quantity by Type (2018-2029)
10.2 South America Neurological Biomarkers Sales Quantity by Application (2018-2029)
10.3 South America Neurological Biomarkers Market Size by Country
10.3.1 South America Neurological Biomarkers Sales Quantity by Country (2018-2029)
10.3.2 South America Neurological Biomarkers Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Neurological Biomarkers Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neurological Biomarkers Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neurological Biomarkers Market Size by Country
11.3.1 Middle East & Africa Neurological Biomarkers Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neurological Biomarkers Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Neurological Biomarkers Market Drivers
12.2 Neurological Biomarkers Market Restraints
12.3 Neurological Biomarkers Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Neurological Biomarkers and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurological Biomarkers
13.3 Neurological Biomarkers Production Process
13.4 Neurological Biomarkers Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurological Biomarkers Typical Distributors
14.3 Neurological Biomarkers Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Neurological Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurological Biomarkers Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Neurological Biomarkers Product and Services
Table 6. Thermo Fisher Scientific Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Thermo Fisher Scientific Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Neurological Biomarkers Product and Services
Table 11. Merck Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 14. Quest Diagnostics Major Business
Table 15. Quest Diagnostics Neurological Biomarkers Product and Services
Table 16. Quest Diagnostics Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Quest Diagnostics Recent Developments/Updates
Table 18. Abbott Basic Information, Manufacturing Base and Competitors
Table 19. Abbott Major Business
Table 20. Abbott Neurological Biomarkers Product and Services
Table 21. Abbott Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Abbott Recent Developments/Updates
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Neurological Biomarkers Product and Services
Table 26. Roche Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Roche Recent Developments/Updates
Table 28. Illumina Basic Information, Manufacturing Base and Competitors
Table 29. Illumina Major Business
Table 30. Illumina Neurological Biomarkers Product and Services
Table 31. Illumina Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Illumina Recent Developments/Updates
Table 33. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. Bio-Rad Laboratories Major Business
Table 35. Bio-Rad Laboratories Neurological Biomarkers Product and Services
Table 36. Bio-Rad Laboratories Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bio-Rad Laboratories Recent Developments/Updates
Table 38. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 39. QIAGEN Major Business
Table 40. QIAGEN Neurological Biomarkers Product and Services
Table 41. QIAGEN Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. QIAGEN Recent Developments/Updates
Table 43. Myriad RBM Basic Information, Manufacturing Base and Competitors
Table 44. Myriad RBM Major Business
Table 45. Myriad RBM Neurological Biomarkers Product and Services
Table 46. Myriad RBM Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Myriad RBM Recent Developments/Updates
Table 48. Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table 49. Cisbio Bioassays Major Business
Table 50. Cisbio Bioassays Neurological Biomarkers Product and Services
Table 51. Cisbio Bioassays Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cisbio Bioassays Recent Developments/Updates
Table 53. Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Athena Diagnostics Major Business
Table 55. Athena Diagnostics Neurological Biomarkers Product and Services
Table 56. Athena Diagnostics Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Athena Diagnostics Recent Developments/Updates
Table 58. BGI Basic Information, Manufacturing Base and Competitors
Table 59. BGI Major Business
Table 60. BGI Neurological Biomarkers Product and Services
Table 61. BGI Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. BGI Recent Developments/Updates
Table 63. Wuxi APP Basic Information, Manufacturing Base and Competitors
Table 64. Wuxi APP Major Business
Table 65. Wuxi APP Neurological Biomarkers Product and Services
Table 66. Wuxi APP Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Wuxi APP Recent Developments/Updates
Table 68. Aepodia Basic Information, Manufacturing Base and Competitors
Table 69. Aepodia Major Business
Table 70. Aepodia Neurological Biomarkers Product and Services
Table 71. Aepodia Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Aepodia Recent Developments/Updates
Table 73. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 74. Proteome Sciences Major Business
Table 75. Proteome Sciences Neurological Biomarkers Product and Services
Table 76. Proteome Sciences Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Proteome Sciences Recent Developments/Updates
Table 78. Genewiz Basic Information, Manufacturing Base and Competitors
Table 79. Genewiz Major Business
Table 80. Genewiz Neurological Biomarkers Product and Services
Table 81. Genewiz Neurological Biomarkers Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Genewiz Recent Developments/Updates
Table 83. Global Neurological Biomarkers Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Neurological Biomarkers Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Neurological Biomarkers Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 86. Market Position of Manufacturers in Neurological Biomarkers, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Neurological Biomarkers Production Site of Key Manufacturer
Table 88. Neurological Biomarkers Market: Company Product Type Footprint
Table 89. Neurological Biomarkers Market: Company Product Application Footprint
Table 90. Neurological Biomarkers New Market Entrants and Barriers to Market Entry
Table 91. Neurological Biomarkers Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Neurological Biomarkers Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Neurological Biomarkers Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Neurological Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Neurological Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Neurological Biomarkers Average Price by Region (2018-2023) & (USD/Unit)
Table 97. Global Neurological Biomarkers Average Price by Region (2024-2029) & (USD/Unit)
Table 98. Global Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Neurological Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Neurological Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Neurological Biomarkers Average Price by Type (2018-2023) & (USD/Unit)
Table 103. Global Neurological Biomarkers Average Price by Type (2024-2029) & (USD/Unit)
Table 104. Global Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Neurological Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Neurological Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Neurological Biomarkers Average Price by Application (2018-2023) & (USD/Unit)
Table 109. Global Neurological Biomarkers Average Price by Application (2024-2029) & (USD/Unit)
Table 110. North America Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Neurological Biomarkers Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Neurological Biomarkers Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Neurological Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Neurological Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Neurological Biomarkers Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Neurological Biomarkers Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Neurological Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Neurological Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Neurological Biomarkers Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Neurological Biomarkers Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Neurological Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Neurological Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Neurological Biomarkers Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Neurological Biomarkers Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Neurological Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Neurological Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Neurological Biomarkers Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Neurological Biomarkers Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Neurological Biomarkers Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Neurological Biomarkers Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Neurological Biomarkers Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Neurological Biomarkers Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Neurological Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Neurological Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Neurological Biomarkers Raw Material
Table 151. Key Manufacturers of Neurological Biomarkers Raw Materials
Table 152. Neurological Biomarkers Typical Distributors
Table 153. Neurological Biomarkers Typical Customers
List of Figures
Figure 1. Neurological Biomarkers Picture
Figure 2. Global Neurological Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurological Biomarkers Consumption Value Market Share by Type in 2022
Figure 4. Proteomics Examples
Figure 5. Genomics Examples
Figure 6. Imaging Examples
Figure 7. Bioinformatics Examples
Figure 8. Others Examples
Figure 9. Global Neurological Biomarkers Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Neurological Biomarkers Consumption Value Market Share by Application in 2022
Figure 11. Diagnostics Examples
Figure 12. Drug Discovery Examples
Figure 13. Personalized Medicine Examples
Figure 14. Others Examples
Figure 15. Global Neurological Biomarkers Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Neurological Biomarkers Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Neurological Biomarkers Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Neurological Biomarkers Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Neurological Biomarkers Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Neurological Biomarkers Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Neurological Biomarkers by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Neurological Biomarkers Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Neurological Biomarkers Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Neurological Biomarkers Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Neurological Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Neurological Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Neurological Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Neurological Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Neurological Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Neurological Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Neurological Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Neurological Biomarkers Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Neurological Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Neurological Biomarkers Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Neurological Biomarkers Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Neurological Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Neurological Biomarkers Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Neurological Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Neurological Biomarkers Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Neurological Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 57. China Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Neurological Biomarkers Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Neurological Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Neurological Biomarkers Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Neurological Biomarkers Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Neurological Biomarkers Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Neurological Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Neurological Biomarkers Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Neurological Biomarkers Market Drivers
Figure 78. Neurological Biomarkers Market Restraints
Figure 79. Neurological Biomarkers Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Neurological Biomarkers in 2022
Figure 82. Manufacturing Process Analysis of Neurological Biomarkers
Figure 83. Neurological Biomarkers Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
